Case report on a BRCA1-related ovarian cancer relapsed after prolonged post-surgical paclitaxel-carboplatin therapy; each of 4 consequent relapses showed complete response to paclitaxel-cisplatin combination. Here, BRCA1 is linked to ovarian carcinoma.